Actyus Private Equity SGIIC, S.A. 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 09:26 am Purchase |
2025-03-31 | 13G | Elicio Therapeutics, Inc. ELTX |
Actyus Private Equity SGIIC, S.A. | 856,382 5.400% |
268,564 (+45.69%) |
Filing |
| 2025-01-07 4:30 pm Purchase |
2023-12-08 | 13G | Elicio Therapeutics, Inc. ELTX |
Actyus Private Equity SGIIC, S.A. | 587,818 5.450% |
587,818 (New Position) |
Filing |